Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 9708
TargetEpidermal growth factor receptor [T790M,L858R](Human)
Dongguan Zhenxing-Beite Medicine Technology

US Patent
LigandPNGBDBM50357312(IBRUTINIB | US9181263, 1 | US9108973, Ref 1 | US92...)
Affinity DataIC50: 4.60nMAssay Description:In the case of Km ATP, EGFR T790M/L858R protein kinase activity was tested by Caliper mobility shift assay (referring to J Biomol Screen 14:31, 2009)...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Dongguan Zhenxing-Beite Medicine Technology

US Patent
LigandPNGBDBM50175583(ACP-196 | Acalabrutinib | US9758524, Example 6 | U...)
Affinity DataIC50: 100nMAssay Description:Activity of BTK protein kinase was tested by Caliper mobility shift assay (referring to J Biomol Screen 14:31, 2009). The compound of the present dis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetTyrosine-protein kinase BTK(Human)
Dongguan Zhenxing-Beite Medicine Technology

US Patent
LigandPNGBDBM483356(US10919899, Compound 25)
Affinity DataIC50: 100nMAssay Description:Activity of BTK protein kinase was tested by Caliper mobility shift assay (referring to J Biomol Screen 14:31, 2009). The compound of the present dis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Dongguan Zhenxing-Beite Medicine Technology

US Patent
LigandPNGBDBM483355(US10919899, Compound 21)
Affinity DataIC50: 100nMAssay Description:Activity of BTK protein kinase was tested by Caliper mobility shift assay (referring to J Biomol Screen 14:31, 2009). The compound of the present dis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Dongguan Zhenxing-Beite Medicine Technology

US Patent
LigandPNGBDBM482870(US10919899, Compound 1 | (S)-1-(2-(8-amino-1-(4-(b...)
Affinity DataIC50: 100nMAssay Description:Activity of BTK protein kinase was tested by Caliper mobility shift assay (referring to J Biomol Screen 14:31, 2009). The compound of the present dis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase Tec(Human)
Dongguan Zhenxing-Beite Medicine Technology

US Patent
LigandPNGBDBM50175583(ACP-196 | Acalabrutinib | US9758524, Example 6 | U...)
Affinity DataIC50: 195nMAssay Description:The inhibitory activities of the compound to Tec, Txk, and ITK of human were performed by Eurofins Pharma Discovery Services UK Limited (UK) of the U...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase Tec(Human)
Dongguan Zhenxing-Beite Medicine Technology

US Patent
LigandPNGBDBM482870(US10919899, Compound 1 | (S)-1-(2-(8-amino-1-(4-(b...)
Affinity DataIC50: 218nMAssay Description:The inhibitory activities of the compound to Tec, Txk, and ITK of human were performed by Eurofins Pharma Discovery Services UK Limited (UK) of the U...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Dongguan Zhenxing-Beite Medicine Technology

US Patent
LigandPNGBDBM483357(US10919899, Compound 29)
Affinity DataIC50: 550nMAssay Description:Activity of BTK protein kinase was tested by Caliper mobility shift assay (referring to J Biomol Screen 14:31, 2009). The compound of the present dis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase TXK(Human)
Dongguan Zhenxing-Beite Medicine Technology

US Patent
LigandPNGBDBM482870(US10919899, Compound 1 | (S)-1-(2-(8-amino-1-(4-(b...)
Affinity DataIC50: 4.54E+3nMAssay Description:The inhibitory activities of the compound to Tec, Txk, and ITK of human were performed by Eurofins Pharma Discovery Services UK Limited (UK) of the U...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase TXK(Human)
Dongguan Zhenxing-Beite Medicine Technology

US Patent
LigandPNGBDBM50175583(ACP-196 | Acalabrutinib | US9758524, Example 6 | U...)
Affinity DataIC50: 5.00E+3nMAssay Description:The inhibitory activities of the compound to Tec, Txk, and ITK of human were performed by Eurofins Pharma Discovery Services UK Limited (UK) of the U...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ITK/TSK(Human)
Dongguan Zhenxing-Beite Medicine Technology

US Patent
LigandPNGBDBM50175583(ACP-196 | Acalabrutinib | US9758524, Example 6 | U...)
Affinity DataIC50: 5.00E+3nMAssay Description:The inhibitory activities of the compound to Tec, Txk, and ITK of human were performed by Eurofins Pharma Discovery Services UK Limited (UK) of the U...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Dongguan Zhenxing-Beite Medicine Technology

US Patent
LigandPNGBDBM483351(US10919899, Compound 5)
Affinity DataIC50: 5.50E+3nMAssay Description:Activity of BTK protein kinase was tested by Caliper mobility shift assay (referring to J Biomol Screen 14:31, 2009). The compound of the present dis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Dongguan Zhenxing-Beite Medicine Technology

US Patent
LigandPNGBDBM483354(US10919899, Compound 17)
Affinity DataIC50: 5.50E+3nMAssay Description:Activity of BTK protein kinase was tested by Caliper mobility shift assay (referring to J Biomol Screen 14:31, 2009). The compound of the present dis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Dongguan Zhenxing-Beite Medicine Technology

US Patent
LigandPNGBDBM483316(US10919899, Compound 2)
Affinity DataIC50: 1.00E+4nMAssay Description:Activity of BTK protein kinase was tested by Caliper mobility shift assay (referring to J Biomol Screen 14:31, 2009). The compound of the present dis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Dongguan Zhenxing-Beite Medicine Technology

US Patent
LigandPNGBDBM483350(US10919899, Compound 3)
Affinity DataIC50: 1.00E+4nMAssay Description:Activity of BTK protein kinase was tested by Caliper mobility shift assay (referring to J Biomol Screen 14:31, 2009). The compound of the present dis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Dongguan Zhenxing-Beite Medicine Technology

US Patent
LigandPNGBDBM483352(US10919899, Compound 6)
Affinity DataIC50: 1.00E+4nMAssay Description:Activity of BTK protein kinase was tested by Caliper mobility shift assay (referring to J Biomol Screen 14:31, 2009). The compound of the present dis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Dongguan Zhenxing-Beite Medicine Technology

US Patent
LigandPNGBDBM483353(US10919899, Compound 9)
Affinity DataIC50: 1.00E+4nMAssay Description:Activity of BTK protein kinase was tested by Caliper mobility shift assay (referring to J Biomol Screen 14:31, 2009). The compound of the present dis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ITK/TSK(Human)
Dongguan Zhenxing-Beite Medicine Technology

US Patent
LigandPNGBDBM482870(US10919899, Compound 1 | (S)-1-(2-(8-amino-1-(4-(b...)
Affinity DataIC50: 1.00E+4nMAssay Description:The inhibitory activities of the compound to Tec, Txk, and ITK of human were performed by Eurofins Pharma Discovery Services UK Limited (UK) of the U...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Dongguan Zhenxing-Beite Medicine Technology

US Patent
LigandPNGBDBM482870(US10919899, Compound 1 | (S)-1-(2-(8-amino-1-(4-(b...)
Affinity DataIC50: 1.00E+4nMAssay Description:In the case of Km ATP, EGFR T790M/L858R protein kinase activity was tested by Caliper mobility shift assay (referring to J Biomol Screen 14:31, 2009)...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Dongguan Zhenxing-Beite Medicine Technology

US Patent
LigandPNGBDBM50175583(ACP-196 | Acalabrutinib | US9758524, Example 6 | U...)
Affinity DataIC50: 1.00E+4nMAssay Description:In the case of Km ATP, EGFR T790M/L858R protein kinase activity was tested by Caliper mobility shift assay (referring to J Biomol Screen 14:31, 2009)...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
Go to US Patent